These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 23877785)
21. Tuberculosis screening of new hospital employees: compliance, clearance to work time, and cost using tuberculin skin test and interferon-gamma release assays. Foster-Chang SA; Manning ML; Chandler L Workplace Health Saf; 2014 Nov; 62(11):460-7. PubMed ID: 25207587 [TBL] [Abstract][Full Text] [Related]
22. Pre-placement screening for tuberculosis in healthcare workers. Giri P; Basu S; Sargeant T; Rimmer A; Pirzada O; Adisesh A Occup Med (Lond); 2014 Oct; 64(7):524-9. PubMed ID: 25135937 [TBL] [Abstract][Full Text] [Related]
23. Private firms form initiative to offer accurate and affordable TB tests. Kay M BMJ; 2013 Apr; 346():f2161. PubMed ID: 23564925 [No Abstract] [Full Text] [Related]
24. A screening strategy for latent tuberculosis in healthcare workers: Cost-effectiveness and budget impact of universal versus targeted screening. Png ME; Yoong J; Ong CWM; Fisher D; Bagdasarian N Infect Control Hosp Epidemiol; 2019 Mar; 40(3):341-349. PubMed ID: 30786941 [TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection. Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306 [TBL] [Abstract][Full Text] [Related]
27. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents. So H; Yuen CS; Yip RM Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971 [TBL] [Abstract][Full Text] [Related]
28. Comparison of cost-effectiveness between the quantiFERON-TB Gold-In-Tube and T-Spot tests for screening health-care workers for latent tuberculosis infection. Mukai S; Shigemura K; Yamamichi F; Kitagawa K; Takami N; Nomi M; Arakawa S; Fujisawa M Int J Mycobacteriol; 2017; 6(1):83-86. PubMed ID: 28317810 [TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness analysis of common tuberculosis screening laboratory tests for hemodialysis patients: An analysis from tropical endemic country, Thailand. Srriwijitalai W; Wiwanitkit V Saudi J Kidney Dis Transpl; 2018; 29(2):476-477. PubMed ID: 29657225 [No Abstract] [Full Text] [Related]
30. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test. Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541 [TBL] [Abstract][Full Text] [Related]
31. Occupational screening of health care workers for tuberculosis infection: tuberculin skin testing or interferon-γ release assays? Pai M; Banaei N Occup Med (Lond); 2013 Oct; 63(7):458-60. PubMed ID: 24097956 [No Abstract] [Full Text] [Related]
32. Costs of QuantiFERON-TB Gold versus tuberculin skin test in Spanish healthcare workers. Linertová R; Alvarez-León EE; García-Pérez L; Serrano-Aguilar P J Hosp Infect; 2010 May; 75(1):52-5. PubMed ID: 20307915 [TBL] [Abstract][Full Text] [Related]
33. Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia. El-Helaly M; Khan W; El-Saed A; Balkhy HH J Infect Public Health; 2014; 7(6):481-8. PubMed ID: 25194817 [TBL] [Abstract][Full Text] [Related]
34. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Mandalakas AM; Hesseling AC; Gie RP; Schaaf HS; Marais BJ; Sinanovic E Thorax; 2013 Mar; 68(3):247-55. PubMed ID: 22717944 [TBL] [Abstract][Full Text] [Related]
35. Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries. Kowada A Travel Med Infect Dis; 2016; 14(5):489-498. PubMed ID: 27238907 [TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study. Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809 [TBL] [Abstract][Full Text] [Related]
37. Serial screening for latent tuberculosis infection in healthcare workers in low-risk settings. Zellweger JP; Rieder HL Am J Respir Crit Care Med; 2014 Jan; 189(1):3-4. PubMed ID: 24381985 [No Abstract] [Full Text] [Related]
38. Prevalence of latent tuberculosis infection among healthcare workers in China as detected by two interferon-gamma release assays. Wei Z; Yang M; Quan B; Wang Y; Wu Y; Ji B J Hosp Infect; 2013 Aug; 84(4):323-5. PubMed ID: 23806839 [TBL] [Abstract][Full Text] [Related]
39. Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands. Erkens CG; Dinmohamed AG; Kamphorst M; Toumanian S; van Nispen-Dobrescu R; Alink M; Oudshoorn N; Mensen M; van den Hof S; Borgdorff M; Verver S Int J Tuberc Lung Dis; 2014 Apr; 18(4):413-20. PubMed ID: 24670695 [TBL] [Abstract][Full Text] [Related]
40. The outcome of a cohort of tuberculin-positive predominantly South Asian new entrants aged 16-34 to the UK: Blackburn 1989-2001. Choudhury IW; West CR; Ormerod LP J Public Health (Oxf); 2014 Sep; 36(3):390-5. PubMed ID: 24277780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]